HPCM
AZN icon

High Pointe Capital Management’s AstraZeneca AZN Stock Holding History

High Pointe Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-13,690
Closed -$1.5M – 87
2020
Q3 		$1.5M Sell
13,690
-200
-1% -$22.2K 1.82% 19
2020
Q2 		$1.47M Sell
13,890
-1,110
-7% -$115K 1.93% 19
2020
Q1 		$1.34M Buy
15,000
+350
+2% +$32.9K 1.91% 20
2019
Q4 		$1.46M Hold
14,650
– – 1.73% 24
2019
Q3 		$1.31M Sell
14,650
-170
-1% -$14.7K 1.79% 19
2019
Q2 		$1.22M Hold
14,820
– – 1.71% 20
2019
Q1 		$1.2M Sell
14,820
-1,070
-7% -$84.3K 1.64% 22
2018
Q4 		$1.21M Buy
15,890
+490
+3% +$38.3K 1.99% 13
2018
Q3 		$1.22M Sell
15,400
-620
-4% -$46.9K 1.64% 27
2018
Q2 		$1.13M Buy
16,020
+6,850
+75% +$493K 1.6% 27
2018
Q1 		$641K Buy
9,170
+640
+8% +$44.3K 0.88% 48
2017
Q4 		$592K Hold
8,530
– – 0.81% 46
2017
Q3 		$578K Buy
8,530
+710
+9% +$44.9K 0.85% 46
2017
Q2 		$533K Buy
7,820
+1,935
+33% +$126K 0.83% 50
2017
Q1 		$367K Hold
5,885
– – 0.58% 55
2016
Q4 		$322K Sell
5,885
-245
-4% -$13.9K 0.53% 55
2016
Q3 		$403K Hold
6,130
– – 0.72% 49
2016
Q2 		$370K Buy
6,130
+1,980
+48% +$115K 0.56% 57
2016
Q1 		$234K Buy
+4,150
New +$249K 0.34% 63

Other funds holding AZN

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

High Pointe Capital Management's AZN Position: Q4 2020 in Review

High Pointe Capital Management sold out of AstraZeneca (AZN) in Q4 2020, closing a stake of 13,690 shares — an estimated $1.5M sold.

High Pointe Capital Management first reported a position in AZN in Q1 2016 and held it in 19 quarters. The position peaked at $1.5M in Q3 2020. 787 funds tracked by Wall St. Rank hold AZN as of Q4 2020.

  • High Pointe Capital Management reported no remaining AstraZeneca position as of Q4 2020 after selling out during the quarter.
  • High Pointe Capital Management sold 13,690 AstraZeneca shares in Q4 2020, an estimated $1.5M.
  • High Pointe Capital Management first reported a position in AstraZeneca in Q1 2016 and held it in 19 quarters.
  • High Pointe Capital Management's AstraZeneca position peaked at $1.5M in Q3 2020.
  • 787 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2020.

Based on High Pointe Capital Management's 13F filing for Q4 2020, filed 8 Feb 2021.